Advertisement
Screener

EVOLUS, INC. (EOLS) Capital Expenditures Incurred but Not yet Paid

2.6 / 5 stars · 40/77 Roast Me

EVOLUS, INC. Capital Expenditures Incurred but Not yet Paid

EVOLUS, INC. (EOLS) reported Capital Expenditures Incurred but Not yet Paid of $499.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05

  • EVOLUS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $487.00K.
  • EVOLUS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $12.00K, a 97.48% decline year-over-year.
  • EVOLUS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was -$101.00K.
  • EVOLUS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $476.00K.
  • EVOLUS, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $695.00K, a 175.79% increase from fiscal 2024.
  • EVOLUS, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $252.00K, a 486.05% increase from fiscal 2023.
  • EVOLUS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $43.00K.
  • EVOLUS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
Period endCapital Expenditures Incurred but Not yet Paid 3 monthCapital Expenditures Incurred but Not yet Paid 6 monthCapital Expenditures Incurred but Not yet Paid 9 monthCapital Expenditures Incurred but Not yet Paid 12 month
2026-06-30$487.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$499.00K
10-Q · filed 2026-08-05
2026-03-31$12.00K
10-Q · filed 2026-05-04
2025-12-31$695.00K
10-K · filed 2026-03-03
2025-06-30-$101.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$375.00K
10-Q · filed 2026-08-05
2025-03-31$476.00K
10-Q · filed 2026-05-04
2024-12-31$252.00K
10-K · filed 2026-03-03
2023-12-31$43.00K
10-K · filed 2026-03-03
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
$0.00
derived: sum of 2 quarters · filed 2023-03-08
$0.00
derived: sum of 3 quarters · filed 2023-03-08
$0.00
10-K · filed 2023-03-08
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$0.00
derived: sum of 2 quarters · filed 2022-11-08
$0.00
10-Q · filed 2022-11-08
$0.00
derived: sum of 4 quarters · filed 2023-03-08
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$0.00
10-Q · filed 2022-08-02
$0.00
derived: sum of 3 quarters · filed 2023-03-08
$0.00
derived: sum of 4 quarters · filed 2023-03-08
2022-03-31$0.00
10-Q · filed 2022-05-10
$0.00
derived: sum of 2 quarters · filed 2023-03-08
$0.00
derived: sum of 3 quarters · filed 2023-03-08
$3.00K
derived: sum of 4 quarters · filed 2023-03-08
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
$0.00
derived: sum of 2 quarters · filed 2023-03-08
$3.00K
derived: sum of 3 quarters · filed 2023-03-08
$10.00K
10-K · filed 2023-03-08
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$3.00K
derived: sum of 2 quarters · filed 2022-11-08
$10.00K
10-Q · filed 2022-11-08
-$71.00K
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$3.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$10.00K
10-Q · filed 2022-08-02
-$71.00K
derived: sum of 3 quarters · filed 2022-08-02
-$71.00K
derived: sum of 4 quarters · filed 2022-08-02
2021-03-31$7.00K
10-Q · filed 2022-05-10
-$74.00K
derived: sum of 2 quarters · filed 2022-05-10
-$74.00K
derived: sum of 3 quarters · filed 2022-05-10
-$161.00K
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31-$81.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
-$81.00K
derived: sum of 2 quarters · filed 2022-03-03
-$168.00K
derived: sum of 3 quarters · filed 2022-03-03
$0.00
10-K · filed 2022-03-03
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
-$87.00K
derived: sum of 2 quarters · filed 2021-11-02
$81.00K
10-Q · filed 2021-11-02
$21.00K
derived: sum of 4 quarters · filed 2021-11-02
2020-06-30-$87.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$81.00K
10-Q · filed 2021-08-04
$21.00K
derived: sum of 3 quarters · filed 2021-08-04
$113.00K
derived: sum of 4 quarters · filed 2021-08-04
2020-03-31$168.00K
10-Q · filed 2021-05-12
$108.00K
derived: sum of 2 quarters · filed 2021-05-12
$200.00K
derived: sum of 3 quarters · filed 2021-05-12
-$95.00K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$60.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$32.00K
derived: sum of 2 quarters · filed 2021-03-25
-$263.00K
derived: sum of 3 quarters · filed 2021-03-25
$87.00K
10-K · filed 2021-03-25
2019-09-30$92.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
-$203.00K
derived: sum of 2 quarters · filed 2020-10-29
$147.00K
10-Q · filed 2020-10-29
$147.00K
derived: sum of 4 quarters · filed 2020-10-29
2019-06-30-$295.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$55.00K
10-Q · filed 2020-08-10
$55.00K
derived: sum of 3 quarters · filed 2020-08-10
$55.00K
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$350.00K
10-Q · filed 2020-05-11
$350.00K
derived: sum of 2 quarters · filed 2020-05-11
$350.00K
derived: sum of 3 quarters · filed 2020-05-11
$350.00K
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$0.00
derived: sum of 2 quarters · filed 2020-02-25
$0.00
derived: sum of 3 quarters · filed 2020-02-25
$0.00
10-K · filed 2020-02-25
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04
$0.00
derived: sum of 2 quarters · filed 2019-11-04
$0.00
10-Q · filed 2019-11-04
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
$0.00
10-Q · filed 2019-08-12
2018-03-31$0.00
10-Q · filed 2019-05-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
ARVINAS, INC. (ARVN)United States$0.510B58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Altimmune, Inc. (ALT)United States$0.593B-6.43